A new study published in Translational Psychiatry, concluded CBD could represent “a completely new mechanism in the treatment of schizophrenia.” The Phase II study was randomized, controlled, and double-blind. Forty two “acutely exacerbated schizophrenic patients” were randomly assigned to a three-week treatment of CBD or a standard antipsychotic medication (amisulpride). In progressive steps, the patients received up to […]